UBS Downgrades Elan (ELN) to Neutral
More News related to ELN
- Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
- Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011
- UBS Downgrades Elan (ELN) to Neutral
- Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease
- Trading Outlook for Elan Corp. Plc. Issued by InvestorSoup.com
More News related to Downgrades
- RBC Upgrades Diamond Rock (DRH) to Outperform, Downgrades Hospitality Properties (HPT) to Sector Perform
- Wedbush Issues Intraday Downgrade on Warner Music (WMG)
- S&P lowers Ciena (CIEN) corporate credit rating from B+ to B
- Broadpoint.AmTech Downgraded Yingli Green Energy (YGE) to Neutral
- Macquarie Downgrades Nexen (NXY) to Neutral
UBS downgrades Elan (NYSE: ELN) from Buy to Neutral.
To see more analyst ratings on ELN Click Here.
Related Categories
DowngradesStocks Mentioned
-0.02Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
